Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s Life Science Investor Konference held in Copenhagen on March 20th 2024.
Økonomisk Ugebrev, serves as a platform for collaboration and investment opportunities. Hamlet BioPharma presented the advances made by the company to a diverse audience of industry leaders and investors and the presentation was followed by lively and inspiring discussions.
The video from the event is now available on Hamlet BioPharma’s web site:
https://hamletbiopharma.com/news/media-archive/
For more information about Økonomisk Ugebrev, please visit Ugebrev’s official website.
